Last reviewed · How we verify
acetaminophen Caplet
Acetaminophen Caplet, marketed by Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division, is a widely recognized over-the-counter pain reliever and fever reducer. A key strength is its well-established brand presence and broad consumer trust. The primary risk is the key composition patent expiry in 2028, which could lead to increased generic competition.
At a glance
| Generic name | acetaminophen Caplet |
|---|---|
| Also known as | Commercial ACM |
| Sponsor | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Postoperative Pain Management in Rhinoplasty (PHASE2)
- A Bioequivalence Study of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) Versus Advil Dual Action Caplets (125 mg/250 mg) and Bioavailability Assessment of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) and Advil Liqui-Gels (200 mg) in Healthy Adult Subjects (PHASE1)
- Study of Acetaminophen (ACM) in Post-operative Dental Pain (PHASE3)
- Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in Combination (PHASE1)
- Study of Acetaminophen (ACE) in Post-operative Dental Pain (PHASE2)
- Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain (PHASE3)
- Evaluation of the Efficacy of Novel Ibuprofen Acetaminophen Combination Formulations in the Treatment of Post-surgical Dental Pain (PHASE2)
- A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |